Guizhou Sanli Pharmaceutical Co.,Ltd (SHA:603439)
China
· Delayed Price · Currency is CNY 11.25
+0.07 (0.63%)
Apr 30, 2026, 3:00 PM CST
SHA:603439 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 200.33 | 389.42 | 476.07 | 571.37 | 570.88 | 544.22 | Upgrade
|
| Trading Asset Securities | 175.96 | 19.93 | 22.95 | 51.5 | 59.91 | 98 | Upgrade
|
| Cash & Short-Term Investments | 376.3 | 409.34 | 499.02 | 622.87 | 630.79 | 642.22 | Upgrade
|
| Cash Growth | -10.24% | -17.97% | -19.89% | -1.26% | -1.78% | 10.72% | Upgrade
|
| Accounts Receivable | 878.55 | 858.34 | 932.12 | 682.86 | 432.82 | 312.8 | Upgrade
|
| Other Receivables | 2.54 | 3.02 | 2.53 | 3.32 | 2.18 | 51.41 | Upgrade
|
| Receivables | 881.08 | 861.35 | 934.65 | 686.18 | 435.01 | 364.21 | Upgrade
|
| Inventory | 207.19 | 222.42 | 320.72 | 175.72 | 98.08 | 88.57 | Upgrade
|
| Other Current Assets | 34.23 | 36.47 | 43.59 | 8.69 | 8.18 | 4.55 | Upgrade
|
| Total Current Assets | 1,499 | 1,530 | 1,798 | 1,493 | 1,172 | 1,100 | Upgrade
|
| Property, Plant & Equipment | 543.04 | 545.57 | 585.15 | 615.13 | 237.4 | 157.91 | Upgrade
|
| Long-Term Investments | 89.39 | 89.6 | 22.55 | 10.08 | 129.77 | 119.13 | Upgrade
|
| Goodwill | 432.63 | 432.63 | 554.61 | 554.61 | 161.66 | - | Upgrade
|
| Other Intangible Assets | 189.62 | 194.28 | 216.13 | 235.23 | 107.3 | 20.38 | Upgrade
|
| Long-Term Deferred Tax Assets | 17.2 | 15.79 | 15.13 | 11.08 | 6.89 | 5.12 | Upgrade
|
| Long-Term Deferred Charges | 0.57 | 0.66 | 0.56 | 0.86 | 1.54 | 2.9 | Upgrade
|
| Other Long-Term Assets | 39.47 | 39.81 | - | - | - | - | Upgrade
|
| Total Assets | 2,811 | 2,848 | 3,192 | 2,920 | 1,817 | 1,405 | Upgrade
|
| Accounts Payable | 111.64 | 112.29 | 342.73 | 247.98 | 165.26 | 98.84 | Upgrade
|
| Accrued Expenses | 12.55 | 34.01 | 67.33 | 39.48 | 31.33 | 16.59 | Upgrade
|
| Short-Term Debt | 498.32 | 548.67 | 351.52 | 255.32 | 205 | 200 | Upgrade
|
| Current Portion of Long-Term Debt | 60.02 | 59.91 | 45.15 | 45.22 | - | - | Upgrade
|
| Current Portion of Leases | - | - | 0.5 | 0.15 | 0.5 | - | Upgrade
|
| Current Income Taxes Payable | 40.45 | 55.3 | 13.84 | 12.77 | 10.91 | 9.4 | Upgrade
|
| Current Unearned Revenue | 4.17 | 5.47 | 7.79 | 8.17 | 78.96 | 5.83 | Upgrade
|
| Other Current Liabilities | 226.75 | 221.53 | 405.59 | 229.92 | 56.72 | 29.76 | Upgrade
|
| Total Current Liabilities | 953.89 | 1,037 | 1,234 | 839.01 | 548.68 | 360.42 | Upgrade
|
| Long-Term Debt | 149.5 | 149.72 | 209.3 | 254.15 | - | - | Upgrade
|
| Long-Term Leases | - | 0.03 | 0.21 | 0.17 | 0.17 | - | Upgrade
|
| Long-Term Unearned Revenue | 38.17 | 39.19 | 42.97 | 35.97 | 12.5 | 12.5 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 21.14 | 21.99 | 25.5 | 28.88 | 6.94 | - | Upgrade
|
| Other Long-Term Liabilities | 87.35 | 87.59 | 85.04 | 52.92 | 10.1 | - | Upgrade
|
| Total Liabilities | 1,250 | 1,336 | 1,597 | 1,211 | 578.4 | 372.93 | Upgrade
|
| Common Stock | 408.93 | 408.93 | 409.8 | 409.86 | 410.86 | 410.86 | Upgrade
|
| Additional Paid-In Capital | 156.47 | 153.26 | 149.04 | 225.12 | 229.69 | 223.39 | Upgrade
|
| Retained Earnings | 1,022 | 977.75 | 1,069 | 876.75 | 625.04 | 423.75 | Upgrade
|
| Treasury Stock | -94.35 | -94.35 | -100.64 | -41.43 | -26.55 | -26.55 | Upgrade
|
| Total Common Equity | 1,493 | 1,446 | 1,527 | 1,470 | 1,239 | 1,031 | Upgrade
|
| Minority Interest | 67.46 | 66.63 | 67.29 | 239.04 | -0.82 | 0.61 | Upgrade
|
| Shareholders' Equity | 1,561 | 1,512 | 1,595 | 1,709 | 1,238 | 1,032 | Upgrade
|
| Total Liabilities & Equity | 2,811 | 2,848 | 3,192 | 2,920 | 1,817 | 1,405 | Upgrade
|
| Total Debt | 707.84 | 758.32 | 606.68 | 555.02 | 205.67 | 200 | Upgrade
|
| Net Cash (Debt) | -331.54 | -348.98 | -107.67 | 67.86 | 425.12 | 442.22 | Upgrade
|
| Net Cash Growth | - | - | - | -84.04% | -3.87% | 16.36% | Upgrade
|
| Net Cash Per Share | -0.80 | -0.83 | -0.26 | 0.16 | 1.03 | 1.07 | Upgrade
|
| Filing Date Shares Outstanding | 403.74 | 470.17 | 405.61 | 408.25 | 410.86 | 410.86 | Upgrade
|
| Total Common Shares Outstanding | 403.74 | 470.17 | 405.61 | 408.25 | 410.86 | 410.86 | Upgrade
|
| Working Capital | 544.91 | 492.42 | 563.53 | 654.46 | 623.38 | 739.12 | Upgrade
|
| Book Value Per Share | 3.70 | 3.07 | 3.77 | 3.60 | 3.02 | 2.51 | Upgrade
|
| Tangible Book Value | 870.96 | 818.69 | 756.61 | 680.48 | 970.09 | 1,011 | Upgrade
|
| Tangible Book Value Per Share | 2.16 | 1.74 | 1.87 | 1.67 | 2.36 | 2.46 | Upgrade
|
| Buildings | - | - | 543.28 | 549.09 | 181.14 | 152.85 | Upgrade
|
| Machinery | - | - | 351.45 | 344.91 | 103.27 | 58.44 | Upgrade
|
| Construction In Progress | - | - | - | 0.04 | 48.59 | 4.17 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.